Hörtnagel Konstanze, Prokisch Holger, Meitinger Thomas
Institute of Human Genetics, GSF Research Centre for Environment and Health, D-85764 Neuherberg, Germany.
Hum Mol Genet. 2003 Feb 1;12(3):321-7. doi: 10.1093/hmg/ddg026.
Mutations in the human PANK2 gene have been shown to occur in autosomal-recessive pantothenate kinase-associated neurodegeneration, a syndrome originally described by Hallervorden and Spatz. The kinase catalyses the first and rate-limiting step in the biosynthesis of coenzyme A, a key molecule in energy metabolism. We have determined the exon-intron structure of the hPANK2 gene and identified two alternatively used first exons. The resulting transcripts encode distinct isoforms of hPANK2, one of which carries an N-terminal extension with a predicted mitochondrial targeting signal. An in vitro import assay and in vivo immunolocalization experiments demonstrate a mitochondrial localization of this isoform. We conclude that the symptoms observed in pantothenate kinase-associated neurodegeneration are caused by a deficiency of the mitochondrial isoform and postulate the existence of a complete intramitochondrial pathway for de novo synthesis of coenzyme A.
人类PANK2基因的突变已被证明会发生在常染色体隐性泛酸激酶相关神经退行性变中,这是一种最初由哈勒沃登和施帕茨描述的综合征。该激酶催化辅酶A生物合成的第一步也是限速步骤,辅酶A是能量代谢中的关键分子。我们已经确定了hPANK2基因的外显子-内含子结构,并鉴定出两个可交替使用的第一外显子。产生的转录本编码hPANK2的不同异构体,其中一种携带带有预测线粒体靶向信号的N端延伸。体外导入试验和体内免疫定位实验证明了这种异构体的线粒体定位。我们得出结论,泛酸激酶相关神经退行性变中观察到的症状是由线粒体异构体的缺乏引起的,并推测存在从头合成辅酶A的完整线粒体内途径。